Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults
- PMID: 24407102
- DOI: 10.1016/j.apmr.2013.12.019
Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults
Abstract
Objective: To assess the frequency and types of adverse events (AEs) related to intrathecal baclofen (ITB) therapy in adults, and associated risk factors.
Design: A prospective, observational cohort study of adults followed up from January 1 to December 31, 2010.
Setting: A neurologic rehabilitation department in a university hospital.
Participants: All consecutive adult subjects (N=158) receiving ITB via a pump, either implanted or followed up during the study period.
Intervention: Not applicable.
Main outcome measures: Frequency and type of AEs.
Results: In 2010, 158 subjects were followed up for ITB therapy, of whom 128 were implanted before 2010 (nonsurgical subjects), and 30 underwent implantation in 2010 (surgical subjects). Of these 30 subjects, 20 were "newly implanted" and 10 were "replacements." The most frequent pathologic disorders were spinal cord injury (42%) and multiple sclerosis (28%). Twenty-eight subjects (18%) experienced a total of 38 AEs. The rate of AEs was .023 per month of ITB treatment. AEs were related to the surgical procedure in 53% of cases, to the device in 29% (predominantly catheter dysfunctions), and to adverse effects of baclofen in 18%. AEs related to the surgical incision (scar complications and collections) were more frequent in replacement than newly implanted subjects (P=.009). No significant association between occurrence of an AE and subject characteristics (age, gait capacity, spinal vs cerebral spasticity, duration of ITB therapy follow-up) was found. Nearly half of the AEs were serious, extending admission time by a mean of 16 days. No AE induced long-term morbidity or death.
Conclusions: The AE rate was relatively low in this cohort. This has to be balanced against the clinical, functional, and quality-of-life improvements, which are expected from ITB therapy.
Keywords: Adverse drug event; Baclofen; Infusion pumps, implantable; Muscle spasticity; Rehabilitation.
Copyright © 2014 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.Clin Rehabil. 2013 Dec;27(12):1137-43. doi: 10.1177/0269215513488607. Epub 2013 Jul 15. Clin Rehabil. 2013. PMID: 23858524
-
Long-term intrathecal baclofen: outcomes after more than 10 years of treatment.PM R. 2014 Jun;6(6):506-513.e1. doi: 10.1016/j.pmrj.2013.12.005. Epub 2013 Dec 17. PM R. 2014. PMID: 24355547
-
Intraventricular baclofen as an alternative to intrathecal baclofen for intractable spasticity or dystonia: outcomes and technical considerations.J Neurosurg Pediatr. 2012 Oct;10(4):315-9. doi: 10.3171/2012.6.PEDS11456. Epub 2012 Aug 3. J Neurosurg Pediatr. 2012. PMID: 22861196
-
Intrathecal baclofen bolus dosing and catheter tip placement in pediatric tone management.Phys Med Rehabil Clin N Am. 2015 Feb;26(1):89-93. doi: 10.1016/j.pmr.2014.09.011. Phys Med Rehabil Clin N Am. 2015. PMID: 25479782 Review.
-
A review of the complications of intrathecal baclofen in patients with cerebral palsy.NeuroRehabilitation. 2007;22(5):383-95. NeuroRehabilitation. 2007. PMID: 18162701 Review.
Cited by
-
Successful Treatment of Stiff Person Syndrome with Intrathecal Baclofen.J Rehabil Med Clin Commun. 2019 Dec 11;2:1000016. doi: 10.2340/20030711-1000016. eCollection 2019. J Rehabil Med Clin Commun. 2019. PMID: 33884117 Free PMC article.
-
European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A.J Rehabil Med. 2022 Jan 3;54:jrm00241. doi: 10.2340/16501977-2877. J Rehabil Med. 2022. PMID: 34608495 Free PMC article.
-
The effect of combined transcranial pulsed current stimulation and transcutaneous electrical nerve stimulation on lower limb spasticity in children with spastic cerebral palsy: a randomized and controlled clinical study.BMC Pediatr. 2021 Mar 24;21(1):141. doi: 10.1186/s12887-021-02615-1. BMC Pediatr. 2021. PMID: 33761932 Free PMC article. Clinical Trial.
-
Implantable Drug Delivery Systems and Foreign Body Reaction: Traversing the Current Clinical Landscape.Bioengineering (Basel). 2021 Dec 9;8(12):205. doi: 10.3390/bioengineering8120205. Bioengineering (Basel). 2021. PMID: 34940358 Free PMC article. Review.
-
Eleven years' experience with Intrathecal Baclofen - Complications, risk factors.Brain Behav. 2018 Mar 30;8(5):e00965. doi: 10.1002/brb3.965. eCollection 2018 May. Brain Behav. 2018. PMID: 29761017 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical